Pleural cavity exploitation in beta-agonist-treated ARDS patients.
Zarogiannis
Sotirios
S
Hatzoglou
Chrissi
C
Gourgoulianis
Konstantinos
K
Molyvdas
Paschalis-Adam
PA
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000336:Aerosols; D000818:Animals; D015633:Extravascular Lung Water / Q000187:drug effects; D006801:Humans; D010539:Permeability / Q000187:drug effects; D010996:Pleural Effusion / Q000188:drug therapy*; D011654:Pulmonary Edema / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D000336:Aerosols